Title : LIPG: an inflammation and cancer modulator - Hong_2021_Cancer.Gene.Ther_28_27 |
Author(s) : Hong C , Deng R , Wang P , Lu X , Zhao X , Wang X , Cai R , Lin J |
Ref : Cancer Gene Therapy , 28 :27 , 2021 |
Abstract :
Endothelial lipase (LIPG/EL) performs fundamental and vital roles in the human body, including cell composition, cytokine expression, and energy provision. Since LIPG predominantly functions as a phospholipase as well as presents low levels of triglyceride lipase activity, it plays an essential role in lipoprotein metabolism, and involves in the metabolic syndromes such as inflammatory response and atherosclerosis. Cytokines significantly affect LIPG expression in endothelial cells in many diseases. Recently, it is suggested that LIPG contributes to cancer initiation and progression, and LIPG attached increasing importance to its potential for future targeted therapy. |
PubMedSearch : Hong_2021_Cancer.Gene.Ther_28_27 |
PubMedID: 32572177 |
Gene_locus related to this paper: human-LIPG |
Gene_locus | human-LIPG |
Hong C, Deng R, Wang P, Lu X, Zhao X, Wang X, Cai R, Lin J (2021)
LIPG: an inflammation and cancer modulator
Cancer Gene Therapy
28 :27
Hong C, Deng R, Wang P, Lu X, Zhao X, Wang X, Cai R, Lin J (2021)
Cancer Gene Therapy
28 :27